Skip to main content
Clinical Trials/JPRN-UMIN000002340
JPRN-UMIN000002340
Completed
Phase 4

Comparison of effects between higher dosages of infliximab and switching to other biologics for rheumatoid arthritis patients with less responsiveness to infliximab therapy (cHAMLET) - cHAMLET

Department of Rheumatosurgery, Osaka City University Medical School0 sites60 target enrollmentAugust 20, 2009

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Rheumatoid Arthritis
Sponsor
Department of Rheumatosurgery, Osaka City University Medical School
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 20, 2009
End Date
July 1, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Rheumatosurgery, Osaka City University Medical School

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients whose DAS28\-ESR are below 3\.2 (DAS28\-CRP\>2\.7\) after low\-dose infliximab (3mg/Kg) therapy at least 5 times

Outcomes

Primary Outcomes

Not specified

Similar Trials